论文信息 - A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors - 字舞流文

A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors

J. Verweij | U. Banerji | M. Garrett | F. Raynaud | J. D. de Bono | R. Kristeleit | D. Papadatos-Pastos | F. Eskens | M. Toal | P. Debnam | L. van Doorn | A. Stewart | L. Hooftman | M. Tall | Matthew Tall